Home

Gina Consylman

CIK 1546358 · Chief Financial Officer · last filed 2026-06-05

Gina Consylman is a Chief Financial Officer who has filed 49 SEC Form 4 insider transactions across 5 companies since 2012. The most recent filing, for ASMB, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$772.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.7M across reported positions. 30 SEC filings were submitted jointly with IRONWOOD PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.67M

Companies

5

Total Filings

49

Lifetime Open-Market Net

-$772.3K

Filer Profile

Reported Address
C/O ASSEMBLY BIOSCIENCES, INC.
TWO TOWER PLACE, 7TH FLOOR
SOUTH SAN FRANCISCO, CA 94080
Related Filers
IRONWOOD PHARMACEUTICALS INC — 30 joint filings, latest 2021-03-30
bluebird bio, Inc. — 3 joint filings, latest 2022-02-03
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ASMB Director — $36.60 — $0 7 2026-06-05
bluebird bio, Inc. (BLUE) Delisted Chief Financial Officer 6,269 $4.97 $31.2K $0 2 2022-02-03
VSTM Director — $8.20 — $0 4 2021-06-30
IRWD SVP, CFO & Treasurer 392,616 $4.26 $1.67M -$645.7K 29 2021-03-30
ANALOGIC CORP (ALOG) Delisted VP-Controller 775 — — -$126.6K 7 2014-03-07

Recent Filings

49 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-05 ASMB Grant (A) — $0 EDGAR
2025-06-09 ASMB Grant (A) — $0 EDGAR
2024-05-30 ASMB Grant (A) — $0 EDGAR
2023-05-30 ASMB Grant (A) — $0 EDGAR
2022-05-27 ASMB Grant (A) — $0 EDGAR
2022-02-03 bluebird bio, Inc. (BLUE) Delisted Grant (A) +25,000 $0 EDGAR
2021-11-16 bluebird bio, Inc. (BLUE) Delisted Other (J) +100,385 $0 EDGAR
2021-06-30 VSTM Grant (A) — $0 EDGAR
2021-05-24 ASMB Grant (A) — $0 EDGAR
2021-03-30 IRWD Grant (A) +56,372 $0 EDGAR
Showing 1–10 of 49
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.